Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice

BACKGROUND: Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM) and also a major cause of end-stage renal disease (ESRD). Olmesartan medoxomil (OM) is an angiotensin II receptor blocker (ARB) and has been shown to exhibit renoprotective effects on a streptozotocin (STZ)-indu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Zhu, Ye, Li, Ze-Liang, Ding, Ao, Yang, Hui, Zhu, Wei-Ping, Cui, Tong-Xia, Zhang, Hui-Tao, Zhang, Hua
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove 2019
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815789/
https://ncbi.nlm.nih.gov/pubmed/31695333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S217826
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items